USFDA inspects Cadila Healthcare’s API facility at Dabhasa

19 Jan 2018 Evaluate

The US Food and Drug Administration (USFDA) has completed an inspection at Cadila Healthcare’s API manufacturing facility at Dabhasa. The facility was inspected in the period from January 15, 2018 to January 19, 2018. At the end of the inspection, no observation (483) was issued.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Zydus Lifesciences Share Price

934.50 -10.65 (-1.13%)
18-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1523.80
Dr. Reddys Lab 5959.10
Cipla 1352.95
Zydus Lifesciences 934.50
Lupin 1599.65
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.